Mylab Discovery Solutions unveils combined RT-PCR test kit for chikungunya, dengue, malaria

If a patient goes for individual test of these seven diseases, it could cost around Rs 8,000, but with Mylab's extended monsoon panel, it will cost less than half of the amount, it added.

Published On 2022-07-16 10:26 GMT   |   Update On 2022-07-16 10:26 GMT

New Delhi: Biotech firm Mylab Discovery Solutions has announced the launch of its combined RT PCR test kit for diseases, including malaria, chikungunya, dengue, and zika.The test kit -- PathoDetect Extended Monsoon Fever Panel -- can differentiate malaria, chikungunya, dengue, zika, leishmaniasis, leptospirosis and salmonellosis, the company said in a statement.If a patient goes for...

Login or Register to read the full article

New Delhi: Biotech firm Mylab Discovery Solutions has announced the launch of its combined RT PCR test kit for diseases, including malaria, chikungunya, dengue, and zika.

The test kit -- PathoDetect Extended Monsoon Fever Panel -- can differentiate malaria, chikungunya, dengue, zika, leishmaniasis, leptospirosis and salmonellosis, the company said in a statement.

If a patient goes for individual test of these seven diseases, it could cost around Rs 8,000, but with Mylab's extended monsoon panel, it will cost less than half of the amount, it added.

Mylab Discovery Solutions founder and managing director Hasmukh Rawal said the precise diagnosis of many of these diseases remains a significant challenge because of the lack of accurate and reliable diagnostic methods.

The 'Extended Monsoon Fever Panel', he said, ''will create a paradigm shift in the diagnosis of seasonal epidemic-prone diseases. Accuracy and speed of diagnosis coupled with its efficiency to distinguish the causative agents will make it an extremely beneficial method to manage these diseases''.

Rawal further said, ''There is a great opportunity for us to use the infrastructure created for control of the COVID-19 virus to monitor the mosquito-borne diseases in elimination programmes. RT-PCR is the most accurate screening solution for detecting vector-borne disease as it was in the case of COVID-19. It can prevent further spread of the diseases and aid in disease elimination.'' The company claimed its combined kit is highly accurate, user-friendly, compact and can process samples to result within 2 hours, therefore, can be implemented for mass testing.

Read also: Shilpa Biologics, Mylab ink pact to enter vaccine, therapeutics segment

Mylab Discovery Solutions Pvt. Ltd., is a Dynamic Biotechnology company, that develops and commercializes diagnostic kits. The company offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, agrigenomics and animal and food safety.

Read also: Mylab buys majority stake in POC testing system developers Sanskritech

Tags:    
Advertisement
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News